Australia markets closed

Chengdu Kanghua Biological Products Co., Ltd. (300841.SZ)

Shenzhen - Shenzhen Delayed price. Currency in CNY
Add to watchlist
60.80+1.20 (+2.01%)
At close: 03:04PM CST
Currency in CNY

Valuation measures4

Market cap (intra-day) 8.19B
Enterprise value 7.34B
Trailing P/E 14.68
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)5.05
Price/book (mrq)2.27
Enterprise value/revenue 4.56
Enterprise value/EBITDA 11.57

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-29.52%
S&P500 52-week change 322.36%
52-week high 388.21
52-week low 344.78
50-day moving average 360.52
200-day moving average 364.64

Share statistics

Avg vol (3-month) 31.96M
Avg vol (10-day) 31.96M
Shares outstanding 5134.65M
Implied shares outstanding 6134.65M
Float 870.71M
% held by insiders 136.54%
% held by institutions 119.47%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.5
Forward annual dividend yield 40.82%
Trailing annual dividend rate 32.00
Trailing annual dividend yield 33.36%
5-year average dividend yield 4N/A
Payout ratio 412.07%
Dividend date 3N/A
Ex-dividend date 424 May 2023
Last split factor 21.5:1
Last split date 325 May 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 34.37%
Operating margin (ttm)56.14%

Management effectiveness

Return on assets (ttm)10.45%
Return on equity (ttm)16.32%

Income statement

Revenue (ttm)1.61B
Revenue per share (ttm)12.05
Quarterly revenue growth (yoy)12.00%
Gross profit (ttm)N/A
EBITDA 717.29M
Net income avi to common (ttm)553.49M
Diluted EPS (ttm)4.14
Quarterly earnings growth (yoy)42.10%

Balance sheet

Total cash (mrq)1.06B
Total cash per share (mrq)7.93
Total debt (mrq)210.19M
Total debt/equity (mrq)5.84%
Current ratio (mrq)4.49
Book value per share (mrq)26.99

Cash flow statement

Operating cash flow (ttm)655.68M
Levered free cash flow (ttm)249.2M